NCT02323672View on ClinicalTrials.gov

Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

October 31, 2014

Conditions
Precancerous ConditionsOral Cancer
All Listed Sponsors
lead

Cairo University

OTHER

NCT02323672 - Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions | Biotech Hunter | Biotech Hunter